A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1018 and Coadministration of BR1018A and BR1018B in Healthy Adult Volunteers

Clinical trial NCT06889012 · COMPLETED

Trial details

NCT number: NCT06889012
Sponsor: Boryung Pharmaceutical Co., Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Essential Hypertension Primary Hypercholesterolemia

Start date: 2025-05-07
Primary completion: 2025-07-23
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.